Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Guillaume, Klausner"'
Publikováno v:
Breast, Vol 54, Iss , Pp 328-330 (2020)
Leptomeningeal carcinomatosis (LC) is an unmet medical need associated with death in 4–6 weeks without treatment, delayed by 4 months in some patients with favorable prognosis and aggressive multimodal therapy. Unfortunately, most clinical trials e
Externí odkaz:
https://doaj.org/article/393ed242a02d42cc9aabc26f41de18e2
Autor:
Galaad Bernard, Guillaume Klausner, Eivind Blais, Charles-Henry Canova, Jean Bourhis, Idriss Troussier
Publikováno v:
Revue Médicale Suisse. 18:1125-1133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d2f11537c04ca9a1033dba6d89806f0
https://doi.org/10.53738/revmed.2022.18.784.1125
https://doi.org/10.53738/revmed.2022.18.784.1125
Autor:
Galaad, Bernard, Guillaume, Klausner, Eivind, Blais, Charles-Henry, Canova, Jean, Bourhis, Idriss, Troussier
Publikováno v:
Revue medicale suisse. 18(784)
This review of the literature provides an overview of the combination of stereotactic radiotherapy (SBRT) with immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI) in oligo-progressive non-small cell lung neoplasia. This combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb755af3442708df27d1ebb9a6236b3f
https://pubmed.ncbi.nlm.nih.gov/35647751
https://pubmed.ncbi.nlm.nih.gov/35647751
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9911aadca1f7d73d10bb6ed6380feac0
https://pubmed.ncbi.nlm.nih.gov/34623486
https://pubmed.ncbi.nlm.nih.gov/34623486
Autor:
Idriss, Troussier, Guillaume, Klausner, Sylvain, Morinière, Eivind, Blais, Jean-Christophe Faivre, Ambroise, Champion, Lionnel, Geoffrois, Carole, Pflumio, Emmanuel, Babin, Philippe, Maingon, Juliette, Thariat
Publikováno v:
Bulletin du cancer. 105(2)
Cervical lymphadenopathies of unknown primary represent 3 % of head and neck cancers. Their diagnostic work up has largely changed in recent years. This review provides an update on diagnostic developments and their potential therapeutic impact.This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10bf2f656121f3374134b68d6dc17b74
https://pubmed.ncbi.nlm.nih.gov/29275831
https://pubmed.ncbi.nlm.nih.gov/29275831